Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Renal Cell × Electroporation × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Carcinoma, Hepatocellular 5 Pancreatic Neoplasms 4 Liver Neoplasms 4 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Diseases 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Bile Duct Neoplasms 1

Interventions

Sunitinib 9 Radiosurgery 9 pazopanib 4 Standard of Care 4 Practice Guidelines as Topic 4 Magnetic Resonance Spectroscopy 4 Surveys and Questionnaires 3 Exercise 3 Everolimus 3 Blood Specimen Collection 3 gallium 68 PSMA-11 2 fludarabine phosphate 2 Sutures 2 Sorafenib 2 Radiofrequency Ablation 2 Peripheral Blood Stem Cell Transplantation 2 Optical Imaging 2 Occupational Therapy 2 Nephrectomy 2 Fluorodeoxyglucose F18 2 Early Intervention, Educational 2 Cyclophosphamide 2 Cryosurgery 2 Busulfan 2 Bevacizumab 2 tivozanib 1 temsirolimus 1 propacetamol 1 etoposide phosphate 1 diacetamate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02335827 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡